Literature DB >> 17049925

Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.

Luis A Videla1, Ramón Rodrigo, Julia Araya, Jaime Poniachik.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is emerging as a major cause of chronic liver disease in association with the rising prevalence of obesity and type 2 diabetes in the population. Oxidative stress and insulin resistance (IR) are major contributors in the pathogenesis of NAFLD and in the progression from steatosis to steatohepatitis. Recently, Houstis and colleagues reported that reactive oxygen species have a causal role in multiple forms of IR, a phenomenon that can further promote exacerbation of oxidative stress. The improvement of the knowledge of these interrelationships should contribute to elucidate pathogenic pathways and design effective treatments for NAFLD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17049925     DOI: 10.1016/j.molmed.2006.10.001

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  49 in total

Review 1.  Roles of liver innate immune cells in nonalcoholic fatty liver disease.

Authors:  Yu-Tao Zhan; Wei An
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

Review 2.  Nonalcoholic fatty liver disease and cardiovascular disease risk.

Authors:  Roger K Schindhelm; Michaela Diamant; Robert J Heine
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

3.  Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice.

Authors:  Shigeru Nakano; Kenji Katsuno; Masayuki Isaji; Tatsuya Nagasawa; Benjamin Buehrer; Susan Walker; William O Wilkison; Bentley Cheatham
Journal:  J Clin Exp Hepatol       Date:  2015-04-28

Review 4.  Unbalanced oxidant-antioxidant status and its effects in pediatric diseases.

Authors:  Valentina Chiavaroli; Cosimo Giannini; Stefania De Marco; Francesco Chiarelli; Angelika Mohn
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

5.  Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms.

Authors:  Luis A Videla
Journal:  World J Hepatol       Date:  2009-10-31

Review 6.  CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH).

Authors:  Sonia M Najjar; Lucia Russo
Journal:  Semin Immunopathol       Date:  2013-11-21       Impact factor: 9.623

Review 7.  The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis.

Authors:  Fatma Ucar; Sevilay Sezer; Serpil Erdogan; Sumeyya Akyol; Ferah Armutcu; Omer Akyol
Journal:  Redox Rep       Date:  2013-06-05       Impact factor: 4.412

8.  Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis.

Authors:  Hana Malínská; Olena Oliyarnyk; Miriam Hubová; Václav Zídek; Vladimír Landa; Miroslava Simáková; Petr Mlejnek; Ludmila Kazdová; Theodore W Kurtz; Michal Pravenec
Journal:  Mol Cell Biochem       Date:  2009-09-12       Impact factor: 3.396

9.  Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes.

Authors:  Donald J Messner; Byung Han Rhieu; Kris V Kowdley
Journal:  Dig Dis Sci       Date:  2013-04-05       Impact factor: 3.199

Review 10.  Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease.

Authors:  Matteo Nicola Dario Di Minno; Anna Russolillo; Roberta Lupoli; Pasquale Ambrosino; Alessandro Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2012-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.